QuVa Pharma, Inc.
Sugar Land, TX, US· latest recorded location
QuVa Pharma, Inc. is named on 5 US grants and 2 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 5
- Published applications
- 2
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Ready to use LET formulations9 Sep 2025US 12,409,155 B1
- Ready to use liquid formulation9 May 2023US 11,642,308 B2
- Drug syringe safely label1 Feb 2022US D942,544 S1Design
- Ready to use liquid formulation23 Mar 2021US 10,952,962 B1
- Ready to use liquid RECK formulation23 Mar 2021US 10,952,963 B2
Most cited
By later US patents